Hollie Franklin, Author at Drugs in Context

Immunotherapy in non-melanoma skin cancer: updates and new perspectives

Paolo Antonio Ascierto MD, Dirk Schadendorf MD, PhD

Article Type

Conference Report

Published

28 Mar 2019

This article provides background on NMSC and describes
the updates and new perspectives that were discussed during
the symposium ‘CSCC It Bridge’ held in Naples, Italy, 28–29
November 2018.

Agents to treat BRAF-mutant lung cancer

Jean G Bustamante Alvarez MD, MS, Gregory A Otterson MD

Article Type

Review

Published

13 Mar 2019

Therapy of episodic ataxias: case report and review of the literature

Daniele Orsucci MD, Laura Maria Raglione MD, Monica Mazzoni MD, Marco Vista MD

Article Type

Review

Published

11 Mar 2019

This paper presents
an illustrative case report followed by a perspective review of genetic ataxias.

The therapeutic role of minocycline in Parkinson’s disease

Seyda Cankaya MD, Baris Cankaya MD, Ulkan Kilic PhD, Ertugrul Kilic PhD, Burak Yulug MD

Article Type

Review

Published

18 Feb 2019

This review summarizes the preclinical and clinical findings suggesting the neuroprotective role of minocycline in Parkinson’s disease.

Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system

Vincenzo Accurso MD, Marco Santoro MD, Salvatrice Mancuso MD, Marisante Napolitano MD, Florinda Di Piazza MD, Antonio Russo MD, Sergio Mario Siragusa MD

Article Type

Case Report

Published

04 Mar 2019

This case report presents initial experience with a patient affected by primary myelofibrosis, retreated with ruxolitinib after a 3-month suspension of
therapy due to clinical decision.